The Florida Legislature
OPPAGA script logo
Office of Program Policy Analysis and Government Accountability

Florida Has Implemented Promising Biotechnology Initiatives, But Faces Challenges, Report No. 06-71, November 2006
Full report in PDF format

  • In recent years, Florida has aggressively pursued developing the state’s biotechnology industry using a multi-faceted approach.  This approach has included recruiting major biotechnology research institutes such as Scripps Florida, the Burnham Institute, and the Torrey Pines Institute, as well as promoting the development of existing biotechnology companies through research and commercialization activities at state research universities and by establishing business incubators.
  • Florida’s initiatives hold great promise and address many of the identified factors that have contributed to successful biotechnology development programs in other states.  However, Florida faces some challenges in developing a strong biotechnology industry, including limited early stage capital for new start-up biotechnology companies. The Legislature may wish to consider creating a privately managed early stage capital fund that invests in start-up biotechnology companies similar to those administered by other states. If the Legislature decides to create such a program, it should require the entity administering the program to establish performance measures and standards and routinely provide performance reports.
  • Further, Florida lacks comprehensive information on the overall costs and effectiveness of its biotechnology initiatives.  The Legislature should make Enterprise Florida, Inc., responsible for preparing a statewide performance report on the various initiatives’ costs and effectiveness.

Which Government Program Summaries contain related information?

Office of Tourism, Trade and Economic Development
Board of Governors
Workforce Services
Enterprise Florida, Inc.
State University System

What other OPPAGA-related materials are available?

  • Report No. 13-06 Florida’s Biotechnology Industry Is Expanding; Cluster Growth Continues to Slowly Progress,published in March 2013.
  • Report No. 11-20 Research Commercialization Matching Grant Program Underway; Additional Performance Data Needed,published in November 2011.
  • Report No. 10-05 Biotechnology Clusters Developing Slowly; Startup Assistance May Encourage Growth, published in January 2010.

Copies of this report in print or alternate accessible format may be obtained by telephone (850/488-0021), by FAX (850/487-9213), in person, or by mail (OPPAGA Report Production, Claude Pepper Building, Room 312, 111 W. Madison St., Tallahassee, FL 32399-1475).
e-mail address:

Reports  |  Home